{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T18:05:49Z","timestamp":1780941949735,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":1579,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.jmii.2010.08.012","type":"journal-article","created":{"date-parts":[[2011,1,24]],"date-time":"2011-01-24T01:46:47Z","timestamp":1295833607000},"page":"364-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan"],"prefix":"10.1016","volume":"44","author":[{"given":"Hsin-Yi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wui-Hsiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuarn-Jang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2010.08.012_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0891-5520(03)00006-0","article-title":"Emerging antibiotic resistance in urinary tract pathogens","volume":"17","author":"Gupta","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jmii.2010.08.012_bib2","first-page":"CR75","article-title":"Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece","volume":"14","author":"Falagas","year":"2008","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jmii.2010.08.012_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum \u03b2-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jmii.2010.08.012_bib4","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1074\/jbc.M411325200","article-title":"Evidence that the fosfomycin target Cys115 in UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is essential for product release","volume":"280","author":"Eschenburg","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmii.2010.08.012_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1749-6632.1974.tb43277.x","article-title":"The mechanism of action of fosfomycin (phosphonomycin)","volume":"235","author":"Kahan","year":"1974","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jmii.2010.08.012_bib6","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institue","year":"2009"},{"key":"10.1016\/j.jmii.2010.08.012_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jmii.2010.08.012_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting; 2008","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jmii.2010.08.012_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/49.1.69","article-title":"Antimicrobial susceptibilities among cilinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University Hospital","volume":"49","author":"Jean","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2010.08.012_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/313719","article-title":"Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum \u03b2\u2013lactamase production in Klebsiella pneumoniae isolates causing bacteremia","volume":"30","author":"Paterson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2010.08.012_bib11","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/322667","article-title":"Epidemiology investigation of fluoroquinolone resistance in infections due to extended-spectrum\u03b2\u2013lactamase\u2013producing Escherichia coli and Klebsiella pneumoniae","volume":"33","author":"Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2010.08.012_bib12","first-page":"59","article-title":"In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum\u03b2\u2013lactamase\u2013producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan","volume":"39","author":"Liao","year":"2006","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2010.08.012_bib13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ijantimicag.2009.07.013","article-title":"In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART study","volume":"34","author":"Hawser","year":"2009","journal-title":"Int J\u00a0Antimicrob Agents"},{"key":"10.1016\/j.jmii.2010.08.012_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.diagmicrobio.2006.11.015","article-title":"In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum \u03b2-lactamase-producing Escherichia coli isolated from urine and blood","volume":"58","author":"Ko","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2010.08.012_bib15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.50.1.368-370.2006","article-title":"In vitro activity of fosfomycin against extended-spectrum-\u03b2-lactamase producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures","volume":"50","author":"de Cueto","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2010.08.012_bib16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.mib.2006.08.011","article-title":"The CTX-M \u03b2-lactamase pandemic","volume":"9","author":"Canton","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.jmii.2010.08.012_bib17","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1128\/JCM.40.12.4666-4669.2002","article-title":"Molecular epidemiology of extended-spectrum-\u03b2-lactamase\u2013producing, fluoroquinolone-resistant isolates of Klebsiella pneumoniae in Taiwan","volume":"40","author":"Yu","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2010.08.012_bib18","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1128\/JCM.38.12.4320-4325.2000","article-title":"Dissemination of CTX-M-3 and CMY-2 \u03b2-lactamases among clinical isolates of Escherichia coli in southern Taiwan","volume":"38","author":"Yan","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2010.08.012_bib19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ijantimicag.2009.07.014","article-title":"Prevalence and types of extended-spectrum-\u03b2-lactamase among urinary Escherichia coli and Klebsiella spp. in New Zealand","volume":"34","author":"Heffernan","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2010.08.012_bib20","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1128\/AAC.01519-08","article-title":"Oral and parenteral therapeutic options for outpatient urinary infections caused by Enterobacteriaceae producing CTX-M extended-spectrum \u03b2-lactamases","volume":"53","author":"Prakash","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2010.08.012_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.diagmicrobio.2007.06.012","article-title":"Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes","volume":"59","author":"Ho","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2010.08.012_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including\u00a0extended-spectrum \u03b2-lactamase producing, Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2010.08.012_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10096-007-0456-4","article-title":"Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin","volume":"27","author":"Falagas","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2010.08.012_bib24","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1464-410X.2008.07809.x","article-title":"Nitrofurantoin: the return of an old friend in the wake of growing resistance","volume":"102","author":"Kashanian","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.jmii.2010.08.012_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1309\/BWQKWB2WN6W5X1CC","article-title":"Cross-class resistance to non-\u03b2-lactam antimicrobials in extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae","volume":"120","author":"Procop","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jmii.2010.08.012_bib26","first-page":"254","article-title":"Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli","volume":"55","author":"Melzer","year":"2007","journal-title":"J\u00a0Infect"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118211000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118211000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:15:55Z","timestamp":1761657355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118211000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1684118211000636"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2010.08.012","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2010.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}